These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19862695)

  • 1. Identifying functional impairment with scores from the repeatable battery for the assessment of neuropsychological status (RBANS).
    Hobson VL; Hall JR; Humphreys-Clark JD; Schrimsher GW; O'Bryant SE
    Int J Geriatr Psychiatry; 2010 May; 25(5):525-30. PubMed ID: 19862695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Japanese version of RBANS (Repeatable Battery for the Assessment of Neuropsychological Status)].
    Yamashima T; Yoshida M; Kumahashi K; Matsui M; Koshino Y; Higashima M; Nagasawa T; Ueki A; Ohtsuka M; Aoki S; Imuro S; Mori N; Takei N; Hoshino R; Minabe Y; Nanba Y; Nanba M; Kira J; Ohyagi Y; Haraoka J; Akimoto J; Miura N; Kimura S; Matsushita M
    No To Shinkei; 2002 Jun; 54(6):463-71. PubMed ID: 12166095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity.
    Randolph C; Tierney MC; Mohr E; Chase TN
    J Clin Exp Neuropsychol; 1998 Jun; 20(3):310-9. PubMed ID: 9845158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age and educational influences on RBANS index scores in a nondemented geriatric sample.
    Gontkovsky ST; Mold JW; Beatty WW
    Clin Neuropsychol; 2002 Aug; 16(3):258-63. PubMed ID: 12607139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informant-rated cognitive symptoms in normal aging, mild cognitive impairment, and dementia. Initial development of an informant-rated screen (Brief Cognitive Scale) for mild cognitive impairment and dementia.
    Krishnan KR; Levy RM; Wagner HR; Chen G; Gersing K; Doraiswamy PM
    Psychopharmacol Bull; 2001; 35(3):79-88. PubMed ID: 12397880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AD8: a brief informant interview to detect dementia.
    Galvin JE; Roe CM; Powlishta KK; Coats MA; Muich SJ; Grant E; Miller JP; Storandt M; Morris JC
    Neurology; 2005 Aug; 65(4):559-64. PubMed ID: 16116116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of percent retention scores on RBANS verbal memory subtests for the diagnosis of Alzheimer's disease and mild cognitive impairment.
    Clark JH; Hobson VL; O'Bryant SE
    Arch Clin Neuropsychol; 2010 Jun; 25(4):318-26. PubMed ID: 20378680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective memory complaints in Chinese subjects with mild cognitive impairment and early Alzheimer's disease.
    Lam LC; Lui VW; Tam CW; Chiu HF
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):876-82. PubMed ID: 16116581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer's disease].
    Rami L; Bosch B; Valls-Pedret C; Caprile C; Sánchez-Valle Díaz R; Molinuevo JL
    Rev Neurol; 2009 Aug 16-31; 49(4):169-74. PubMed ID: 19621317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity and reliability of the Korean version of the AD8 informant interview (K-AD8) in dementia.
    Ryu HJ; Kim HJ; Han SH
    Alzheimer Dis Assoc Disord; 2009; 23(4):371-6. PubMed ID: 19561437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of RBANS test (Repeatable Battery for the Assessment of Neuropsychological Status) in neurocognitive testing of patients suffering from schizophrenia and dementia].
    Juhász LZ; Kemény K; Linka E; Sántha J; Bartkó G
    Ideggyogy Sz; 2003 Sep; 56(9-10):303-8. PubMed ID: 14608951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Clock Drawing Test for dementia of the Alzheimer's type: A comparison of three scoring methods in a memory disorders clinic.
    Brodaty H; Moore CM
    Int J Geriatr Psychiatry; 1997 Jun; 12(6):619-27. PubMed ID: 9215942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Repeatable Battery for the Assessment of Neuropsychological Status as a screening strategy for HIV-Associated Neurocognitive Disorders.
    Costaggiu D; Pinna E; Serchisu L; Barcellona D; Piano P; Ortu F; Marongiu F; Mandas A
    AIDS Care; 2021 Mar; 33(3):357-363. PubMed ID: 32183560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeatable battery for the assessment of neuropsychological status effort index performance in a medically ill geriatric sample.
    Hook JN; Marquine MJ; Hoelzle JB
    Arch Clin Neuropsychol; 2009 May; 24(3):231-5. PubMed ID: 19549722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing the subcortical dementia syndrome of Parkinson's disease using the RBANS.
    Beatty WW; Ryder KA; Gontkovsky ST; Scott JG; McSwan KL; Bharucha KJ
    Arch Clin Neuropsychol; 2003 Jul; 18(5):509-20. PubMed ID: 14591446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japanese version of the Frontal Assessment Battery for dementia.
    Kugo A; Terada S; Ata T; Ido Y; Kado Y; Ishihara T; Hikiji M; Fujisawa Y; Sasaki K; Kuroda S
    Psychiatry Res; 2007 Sep; 153(1):69-75. PubMed ID: 17599465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging.
    Estévez-González A; Kulisevsky J; Boltes A; Otermín P; García-Sánchez C
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):1021-8. PubMed ID: 14618554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the validity of deriving clinical dementia rating (CDR) global scores from independently-obtained functional rating scale (FRS) scores in vascular dementia with and without Alzheimer's disease.
    Lanctôt KL; Hsiung GY; Feldman HH; Masoud ST; Sham L; Herrmann N
    Int J Geriatr Psychiatry; 2009 Oct; 24(10):1174-6. PubMed ID: 19768698
    [No Abstract]   [Full Text] [Related]  

  • 20. The Repeatable Battery for the Assessment of Neuropsychological Status effort scale.
    Novitski J; Steele S; Karantzoulis S; Randolph C
    Arch Clin Neuropsychol; 2012 Mar; 27(2):190-5. PubMed ID: 22277124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.